nach oben

Wiener Medizinische Wochenschrift

Erschienen in:

02.11.2021 | case report

A case report of posttraumatic stress disorder at the end of life

verfasst von: Dr. Tabea Riss

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 7-8/2022

Einloggen, um Zugang zu erhalten

Summary

A case of posttraumatic stress disorder (PTSD) in the last days of life is presented. It shows insufficient pharmacological therapy and PTSD that was not recognized early enough. We discuss the dilemma caused by the necessity of a long-term psychotherapy and the challenge of little time being left at the end of life. Additionally, a language barrier can be a main reason for misinterpreting symptoms of PTSD.

Vorheriger Artikel Torquated large ovarian lymphoma as a cause of acute abdomen: a case report of diffuse large B-cell ovarian lymphoma with a germinal center B-cell-like phenotype

Nächster Artikel Palliative Care bei über 80-jährigen Patienten mit COVID‑19-Pneumonie auf der Intensivstation – invasive Beatmung zielführend?

Glick DM, Cook JM, Moye J, Kaiser AP. Assessment and treatment considerations for post traumatic stress disorder at end of life. Am J Hosp Palliat Care. 2018;35(8):1133–9. https://doi.org/10.1177/1049909118756656.CrossRefPubMedCentralPubMed

Abdallah CG, Averill LA, Akiki TJ, Raza M, Averill CL, Gomaa H, et al. The neurobiology and pharmacotherapy of posttraumatic stress disorder. Annu Rev Pharmacol Toxicol. 2019;59:171–89. https://doi.org/10.1146/annurev-pharmtox-010818-021701.CrossRefPubMed

Koenen KC, Ratanatharathorn A, Ng L, McLaughlin KA, Bromet EJ, Stein DJ, et al. Posttraumatic stress disorder in the world mental health surveys. Psychol Med. 2017;47(13):2260–74. https://doi.org/10.1017/S0033291717000708.CrossRefPubMedCentralPubMed

Fulton JJ, Calhoun PS, Wagner HR, Schry AR, Hair LP, Feeling N, et al. The prevalence of posttraumatic stress disorder in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans: a meta-analysis. J Anxiety Disord. 2015;31:98–107. https://doi.org/10.1016/j.janxdis.2015.02.003.CrossRefPubMed

Abdallah CG, Averill LA, Krystal JH. Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Ann N Y Acad Sci. 2015a;1344(1):66–77. https://doi.org/10.1111/nyas.12718.CrossRefPubMedCentralPubMed

Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2015b;66:509–23. https://doi.org/10.1146/annurev-med-053013-062946.CrossRefPubMed

Averill LA, Purohit P, Averill CL, Boesl MA, Krystal JH, Abdallah CG. Glutamate dysregulation and glutamatergic therapeutics for PTSD: evidence from human studies. Neurosci Lett. 2017;649:147–55. https://doi.org/10.1016/j.neulet.2016.11.064.CrossRefPubMed

Krystal JH, Abdallah CG, Averill LA, Kelmendi B, Harpaz-Rotem I, Sanacora G, et al. Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic. Curr Psychiatry Rep. 2017;19(10):74. https://doi.org/10.1007/s11920-017-0829-z.PMID:.CrossRefPubMedCentralPubMed

Ozer EJ, Best SR, Lipsey TL, Weiss DS. Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull. 2003;129(1):52–73. https://doi.org/10.1037/0033-2909.129.1.52.PMID:.CrossRefPubMed

10.

Zoladz PR, Diamond DM. Current status on behavioral and biological markers of PTSD: a search for clarity in a conflicting literature. Neurosci Biobehav Rev. 2013;37(5):860–95. https://doi.org/10.1016/j.neubiorev.2013.03.024.CrossRefPubMed

11.

Forbes D, Creamer M, Bisson JI, Cohen JA, Crow BE, Foa EB, et al. A guide to guidelines for the treatment of PTSD and related conditions. J Trauma Stress. 2010;23(5):537–52. https://doi.org/10.1002/jts.20565.CrossRefPubMed

12.

Friedman MJ, Bernardy NC. Considering future pharmacotherapy for PTSD. Neurosci Lett. 2017;649:181–5. https://doi.org/10.1016/j.neulet.2016.11.048.CrossRefPubMed

13.

Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351–4. https://doi.org/10.1016/s0006-3223(99)00230-9.CrossRefPubMed

14.

McGirr A, Berlim MT, Bond DJ, Fleck MP, Yatham LN, Lam RW. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med. 2015;45(4):693–704. https://doi.org/10.1017/S0033291714001603.CrossRefPubMed

15.

Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(6):681–8. https://doi.org/10.1001/jamapsychiatry.2014.62.PMID:.CrossRefPubMed

16.

Krystal JH, Rosenheck RA, Cramer JA, Vessicchio JC, Jones KM, Vertrees JE, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493–502. https://doi.org/10.1001/jama.2011.1080.PMID:.CrossRefPubMed

17.

Guina J, Rossetter SR, DeRhodes BJ, Nahhas RW, Welton RS. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015;21(4):281–303. https://doi.org/10.1097/PRA.0000000000000091.CrossRefPubMed

18.

Kelmendi B, Adams TG, Yarnell S, Southwick S, Abdallah CG, Krystal JH. PTSD: from neurobiology to pharmacological treatments. Eur J Psychotraumatol. 2016;7:31858. https://doi.org/10.3402/ejpt.v7.31858.CrossRefPubMed

19.

Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, et al. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry. 2020;177(5):391–410. https://doi.org/10.1176/appi.ajp.2019.19010035.CrossRefPubMed

20.

Ganzel BL. Trauma-informed hospice and palliative care. Gerontologist. 2018;58(3):409–19. https://doi.org/10.1093/geront/gnw146.CrossRefPubMed

21.

Hosie A, Davidson PM, Agar M, Sanderson CR, Phillips J. Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review. Palliat Med. 2013;27(6):486–98. https://doi.org/10.1177/0269216312457214.CrossRefPubMed

22.

Moye J, Rouse SJ. Posttraumatic stress in older adults: when medical diagnoses or treatments cause traumatic stress. Psychiatr Clin North Am. 2015;38(1):45–57. https://doi.org/10.1016/j.psc.2014.11.003.CrossRefPubMed

23.

Beng TS, Chin LE, Guan NC, Yee A, Wu C, Jane LE, et al. Mindfulness-based supportive therapy (MBST): proposing a palliative psychotherapy from a conceptual perspective to address suffering in palliative care. Am J Hosp Palliat Care. 2015;32(2):144–60. https://doi.org/10.1177/1049909113508640.CrossRefPubMed

24.

Feldman DB, Sorocco KH, Bratkovich KL. Treatment of posttraumatic stress disorder at the end-of-life: application of the Stepwise Psychosocial Palliative Care model. Palliat Support Care. 2014;12(3):233–43. https://doi.org/10.1017/S1478951513000370.CrossRefPubMed

25.

Strieder M, Pecherstorfer M, Kreye G. Symptomatic treatment of dyspnea in advanced cancer patients: a narrative review of the current literature. Wien Med Wochenschr. 2018;168(13-14):333–43. https://doi.org/10.1007/s10354-017-0600-4.CrossRefPubMed

26.

Weixler D, Roider-Schur S, Likar R, Bozzaro C, Daniczek T, Feichtner A, Gabl C, Hammerl-Ferrari B, Kletecka-Pulker M, Körtner UH, Kössler H, Meran JG, Miksovsky A, Pusswald B, Wienerroither T, Watzke H. Austrian guideline for palliative sedation therapy (long version): Results of a Delphi process of the Austrian Palliative Society (OPG). Wien Med Wochenschr. 2017;167(1–2):31–48. https://doi.org/10.1007/s10354-016-0533-3. Epub 2016 Dec 6. PMID: 27924420 German.CrossRefPubMed

27.

Beller EM, van Driel ML, McGregor L, Truong S, Mitchell G. Palliative pharmacological sedation for terminally ill adults. Cochrane Database Syst Rev. 2015;1:CD10206. https://doi.org/10.1002/14651858.CD010206.pub2.PMID:.CrossRefPubMed

Titel: A case report of posttraumatic stress disorder at the end of life
verfasst von: Dr. Tabea Riss
Publikationsdatum: 02.11.2021
Verlag: Springer Vienna
Erschienen in: Wiener Medizinische Wochenschrift / Ausgabe 7-8/2022
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI: https://doi.org/10.1007/s10354-021-00892-0

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7-8/2022

Klinische Ethikberatung in der außerklinischen Langzeitpflege durch den Landesverband Hospiz OÖ – Bericht der ersten 5 Jahre

Torquated large ovarian lymphoma as a cause of acute abdomen: a case report of diffuse large B-cell ovarian lymphoma with a germinal center B-cell-like phenotype

Briefsammlung Wittelshöfer

Palliative Care bei über 80-jährigen Patienten mit COVID‑19-Pneumonie auf der Intensivstation – invasive Beatmung zielführend?

Welche Intervention ist bei Patienten mit Chorea Huntington im Endstadium sinnvoll?

Gesundheits- und krankheitsbezogene Daten von Patienten auf Palliativstationen der onkologischen Spitzenzentren und anderer Krankenhäuser im Vergleich – Daten aus dem Hospiz- und Palliativregister